table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Cancer Targeted Therapy Market Size Analysis from 2023 to 2028
1.5.1 Global Cancer Targeted Therapy Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Cancer Targeted Therapy Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Cancer Targeted Therapy Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Cancer Targeted Therapy Industry Impact
Chapter 2 Global Cancer Targeted Therapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global Cancer Targeted Therapy (Volume and Value) by Type
2.1.1 Global Cancer Targeted Therapy Consumption and Market Share by Type (2017-2022)
2.1.2 Global Cancer Targeted Therapy Revenue and Market Share by Type (2017-2022)
2.2 Global Cancer Targeted Therapy (Volume and Value) by Application
2.2.1 Global Cancer Targeted Therapy Consumption and Market Share by Application (2017-2022)
2.2.2 Global Cancer Targeted Therapy Revenue and Market Share by Application (2017-2022)
2.3 Global Cancer Targeted Therapy (Volume and Value) by Regions
2.3.1 Global Cancer Targeted Therapy Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Cancer Targeted Therapy Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Cancer Targeted Therapy Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Cancer Targeted Therapy Consumption by Regions (2017-2022)
4.2 North America Cancer Targeted Therapy Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Cancer Targeted Therapy Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Cancer Targeted Therapy Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Cancer Targeted Therapy Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Cancer Targeted Therapy Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Cancer Targeted Therapy Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Cancer Targeted Therapy Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Cancer Targeted Therapy Sales, Consumption, Export, Import (2017-2022)
4.10 South America Cancer Targeted Therapy Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Cancer Targeted Therapy Market Analysis
5.1 North America Cancer Targeted Therapy Consumption and Value Analysis
5.1.1 North America Cancer Targeted Therapy Market Under COVID-19
5.2 North America Cancer Targeted Therapy Consumption Volume by Types
5.3 North America Cancer Targeted Therapy Consumption Structure by Application
5.4 North America Cancer Targeted Therapy Consumption by Top Countries
5.4.1 United States Cancer Targeted Therapy Consumption Volume from 2017 to 2022
5.4.2 Canada Cancer Targeted Therapy Consumption Volume from 2017 to 2022
5.4.3 Mexico Cancer Targeted Therapy Consumption Volume from 2017 to 2022
Chapter 6 East Asia Cancer Targeted Therapy Market Analysis
6.1 East Asia Cancer Targeted Therapy Consumption and Value Analysis
6.1.1 East Asia Cancer Targeted Therapy Market Under COVID-19
6.2 East Asia Cancer Targeted Therapy Consumption Volume by Types
6.3 East Asia Cancer Targeted Therapy Consumption Structure by Application
6.4 East Asia Cancer Targeted Therapy Consumption by Top Countries
6.4.1 China Cancer Targeted Therapy Consumption Volume from 2017 to 2022
6.4.2 Japan Cancer Targeted Therapy Consumption Volume from 2017 to 2022
6.4.3 South Korea Cancer Targeted Therapy Consumption Volume from 2017 to 2022
Chapter 7 Europe Cancer Targeted Therapy Market Analysis
7.1 Europe Cancer Targeted Therapy Consumption and Value Analysis
7.1.1 Europe Cancer Targeted Therapy Market Under COVID-19
7.2 Europe Cancer Targeted Therapy Consumption Volume by Types
7.3 Europe Cancer Targeted Therapy Consumption Structure by Application
7.4 Europe Cancer Targeted Therapy Consumption by Top Countries
7.4.1 Germany Cancer Targeted Therapy Consumption Volume from 2017 to 2022
7.4.2 UK Cancer Targeted Therapy Consumption Volume from 2017 to 2022
7.4.3 France Cancer Targeted Therapy Consumption Volume from 2017 to 2022
7.4.4 Italy Cancer Targeted Therapy Consumption Volume from 2017 to 2022
7.4.5 Russia Cancer Targeted Therapy Consumption Volume from 2017 to 2022
7.4.6 Spain Cancer Targeted Therapy Consumption Volume from 2017 to 2022
7.4.7 Netherlands Cancer Targeted Therapy Consumption Volume from 2017 to 2022
7.4.8 Switzerland Cancer Targeted Therapy Consumption Volume from 2017 to 2022
7.4.9 Poland Cancer Targeted Therapy Consumption Volume from 2017 to 2022
Chapter 8 South Asia Cancer Targeted Therapy Market Analysis
8.1 South Asia Cancer Targeted Therapy Consumption and Value Analysis
8.1.1 South Asia Cancer Targeted Therapy Market Under COVID-19
8.2 South Asia Cancer Targeted Therapy Consumption Volume by Types
8.3 South Asia Cancer Targeted Therapy Consumption Structure by Application
8.4 South Asia Cancer Targeted Therapy Consumption by Top Countries
8.4.1 India Cancer Targeted Therapy Consumption Volume from 2017 to 2022
8.4.2 Pakistan Cancer Targeted Therapy Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Cancer Targeted Therapy Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Cancer Targeted Therapy Market Analysis
9.1 Southeast Asia Cancer Targeted Therapy Consumption and Value Analysis
9.1.1 Southeast Asia Cancer Targeted Therapy Market Under COVID-19
9.2 Southeast Asia Cancer Targeted Therapy Consumption Volume by Types
9.3 Southeast Asia Cancer Targeted Therapy Consumption Structure by Application
9.4 Southeast Asia Cancer Targeted Therapy Consumption by Top Countries
9.4.1 Indonesia Cancer Targeted Therapy Consumption Volume from 2017 to 2022
9.4.2 Thailand Cancer Targeted Therapy Consumption Volume from 2017 to 2022
9.4.3 Singapore Cancer Targeted Therapy Consumption Volume from 2017 to 2022
9.4.4 Malaysia Cancer Targeted Therapy Consumption Volume from 2017 to 2022
9.4.5 Philippines Cancer Targeted Therapy Consumption Volume from 2017 to 2022
9.4.6 Vietnam Cancer Targeted Therapy Consumption Volume from 2017 to 2022
9.4.7 Myanmar Cancer Targeted Therapy Consumption Volume from 2017 to 2022
Chapter 10 Middle East Cancer Targeted Therapy Market Analysis
10.1 Middle East Cancer Targeted Therapy Consumption and Value Analysis
10.1.1 Middle East Cancer Targeted Therapy Market Under COVID-19
10.2 Middle East Cancer Targeted Therapy Consumption Volume by Types
10.3 Middle East Cancer Targeted Therapy Consumption Structure by Application
10.4 Middle East Cancer Targeted Therapy Consumption by Top Countries
10.4.1 Turkey Cancer Targeted Therapy Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Cancer Targeted Therapy Consumption Volume from 2017 to 2022
10.4.3 Iran Cancer Targeted Therapy Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Cancer Targeted Therapy Consumption Volume from 2017 to 2022
10.4.5 Israel Cancer Targeted Therapy Consumption Volume from 2017 to 2022
10.4.6 Iraq Cancer Targeted Therapy Consumption Volume from 2017 to 2022
10.4.7 Qatar Cancer Targeted Therapy Consumption Volume from 2017 to 2022
10.4.8 Kuwait Cancer Targeted Therapy Consumption Volume from 2017 to 2022
10.4.9 Oman Cancer Targeted Therapy Consumption Volume from 2017 to 2022
Chapter 11 Africa Cancer Targeted Therapy Market Analysis
11.1 Africa Cancer Targeted Therapy Consumption and Value Analysis
11.1.1 Africa Cancer Targeted Therapy Market Under COVID-19
11.2 Africa Cancer Targeted Therapy Consumption Volume by Types
11.3 Africa Cancer Targeted Therapy Consumption Structure by Application
11.4 Africa Cancer Targeted Therapy Consumption by Top Countries
11.4.1 Nigeria Cancer Targeted Therapy Consumption Volume from 2017 to 2022
11.4.2 South Africa Cancer Targeted Therapy Consumption Volume from 2017 to 2022
11.4.3 Egypt Cancer Targeted Therapy Consumption Volume from 2017 to 2022
11.4.4 Algeria Cancer Targeted Therapy Consumption Volume from 2017 to 2022
11.4.5 Morocco Cancer Targeted Therapy Consumption Volume from 2017 to 2022
Chapter 12 Oceania Cancer Targeted Therapy Market Analysis
12.1 Oceania Cancer Targeted Therapy Consumption and Value Analysis
12.2 Oceania Cancer Targeted Therapy Consumption Volume by Types
12.3 Oceania Cancer Targeted Therapy Consumption Structure by Application
12.4 Oceania Cancer Targeted Therapy Consumption by Top Countries
12.4.1 Australia Cancer Targeted Therapy Consumption Volume from 2017 to 2022
12.4.2 New Zealand Cancer Targeted Therapy Consumption Volume from 2017 to 2022
Chapter 13 South America Cancer Targeted Therapy Market Analysis
13.1 South America Cancer Targeted Therapy Consumption and Value Analysis
13.1.1 South America Cancer Targeted Therapy Market Under COVID-19
13.2 South America Cancer Targeted Therapy Consumption Volume by Types
13.3 South America Cancer Targeted Therapy Consumption Structure by Application
13.4 South America Cancer Targeted Therapy Consumption Volume by Major Countries
13.4.1 Brazil Cancer Targeted Therapy Consumption Volume from 2017 to 2022
13.4.2 Argentina Cancer Targeted Therapy Consumption Volume from 2017 to 2022
13.4.3 Columbia Cancer Targeted Therapy Consumption Volume from 2017 to 2022
13.4.4 Chile Cancer Targeted Therapy Consumption Volume from 2017 to 2022
13.4.5 Venezuela Cancer Targeted Therapy Consumption Volume from 2017 to 2022
13.4.6 Peru Cancer Targeted Therapy Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Cancer Targeted Therapy Consumption Volume from 2017 to 2022
13.4.8 Ecuador Cancer Targeted Therapy Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Cancer Targeted Therapy Business
14.1 Advaxis
14.1.1 Advaxis Company Profile
14.1.2 Advaxis Cancer Targeted Therapy Product Specification
14.1.3 Advaxis Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Bind Therapeutics
14.2.1 Bind Therapeutics Company Profile
14.2.2 Bind Therapeutics Cancer Targeted Therapy Product Specification
14.2.3 Bind Therapeutics Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Boehringer Ingelheim
14.3.1 Boehringer Ingelheim Company Profile
14.3.2 Boehringer Ingelheim Cancer Targeted Therapy Product Specification
14.3.3 Boehringer Ingelheim Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Bristol Mayer Squibb
14.4.1 Bristol Mayer Squibb Company Profile
14.4.2 Bristol Mayer Squibb Cancer Targeted Therapy Product Specification
14.4.3 Bristol Mayer Squibb Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Celldex Therapeutics
14.5.1 Celldex Therapeutics Company Profile
14.5.2 Celldex Therapeutics Cancer Targeted Therapy Product Specification
14.5.3 Celldex Therapeutics Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Dendreon Corporation
14.6.1 Dendreon Corporation Company Profile
14.6.2 Dendreon Corporation Cancer Targeted Therapy Product Specification
14.6.3 Dendreon Corporation Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Eli Lily
14.7.1 Eli Lily Company Profile
14.7.2 Eli Lily Cancer Targeted Therapy Product Specification
14.7.3 Eli Lily Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 GalaxoSmithKline
14.8.1 GalaxoSmithKline Company Profile
14.8.2 GalaxoSmithKline Cancer Targeted Therapy Product Specification
14.8.3 GalaxoSmithKline Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Galena Biopharma
14.9.1 Galena Biopharma Company Profile
14.9.2 Galena Biopharma Cancer Targeted Therapy Product Specification
14.9.3 Galena Biopharma Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Genetech
14.10.1 Genetech Company Profile
14.10.2 Genetech Cancer Targeted Therapy Product Specification
14.10.3 Genetech Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 ImmunoCellular Therapeutics
14.11.1 ImmunoCellular Therapeutics Company Profile
14.11.2 ImmunoCellular Therapeutics Cancer Targeted Therapy Product Specification
14.11.3 ImmunoCellular Therapeutics Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 ImmunoGen
14.12.1 ImmunoGen Company Profile
14.12.2 ImmunoGen Cancer Targeted Therapy Product Specification
14.12.3 ImmunoGen Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Inovio Pharmaceuticals
14.13.1 Inovio Pharmaceuticals Company Profile
14.13.2 Inovio Pharmaceuticals Cancer Targeted Therapy Product Specification
14.13.3 Inovio Pharmaceuticals Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Johnson & Johnson
14.14.1 Johnson & Johnson Company Profile
14.14.2 Johnson & Johnson Cancer Targeted Therapy Product Specification
14.14.3 Johnson & Johnson Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 NeoStem Oncology
14.15.1 NeoStem Oncology Company Profile
14.15.2 NeoStem Oncology Cancer Targeted Therapy Product Specification
14.15.3 NeoStem Oncology Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 NewLink Genetics
14.16.1 NewLink Genetics Company Profile
14.16.2 NewLink Genetics Cancer Targeted Therapy Product Specification
14.16.3 NewLink Genetics Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 Northwest Biotherapeutics
14.17.1 Northwest Biotherapeutics Company Profile
14.17.2 Northwest Biotherapeutics Cancer Targeted Therapy Product Specification
14.17.3 Northwest Biotherapeutics Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Merck
14.18.1 Merck Company Profile
14.18.2 Merck Cancer Targeted Therapy Product Specification
14.18.3 Merck Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.19 Novartis
14.19.1 Novartis Company Profile
14.19.2 Novartis Cancer Targeted Therapy Product Specification
14.19.3 Novartis Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.20 Peregrine Pharmaceuticals
14.20.1 Peregrine Pharmaceuticals Company Profile
14.20.2 Peregrine Pharmaceuticals Cancer Targeted Therapy Product Specification
14.20.3 Peregrine Pharmaceuticals Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.21 Pfizer
14.21.1 Pfizer Company Profile
14.21.2 Pfizer Cancer Targeted Therapy Product Specification
14.21.3 Pfizer Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.22 Roche
14.22.1 Roche Company Profile
14.22.2 Roche Cancer Targeted Therapy Product Specification
14.22.3 Roche Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.23 Sanofi
14.23.1 Sanofi Company Profile
14.23.2 Sanofi Cancer Targeted Therapy Product Specification
14.23.3 Sanofi Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.24 Seattle Genetics
14.24.1 Seattle Genetics Company Profile
14.24.2 Seattle Genetics Cancer Targeted Therapy Product Specification
14.24.3 Seattle Genetics Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.25 Teva
14.25.1 Teva Company Profile
14.25.2 Teva Cancer Targeted Therapy Product Specification
14.25.3 Teva Cancer Targeted Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Cancer Targeted Therapy Market Forecast (2023-2028)
15.1 Global Cancer Targeted Therapy Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Cancer Targeted Therapy Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Cancer Targeted Therapy Value and Growth Rate Forecast (2023-2028)
15.2 Global Cancer Targeted Therapy Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Cancer Targeted Therapy Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Cancer Targeted Therapy Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Cancer Targeted Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Cancer Targeted Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Cancer Targeted Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Cancer Targeted Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Cancer Targeted Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Cancer Targeted Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Cancer Targeted Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Cancer Targeted Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Cancer Targeted Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Cancer Targeted Therapy Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Cancer Targeted Therapy Consumption Forecast by Type (2023-2028)
15.3.2 Global Cancer Targeted Therapy Revenue Forecast by Type (2023-2028)
15.3.3 Global Cancer Targeted Therapy Price Forecast by Type (2023-2028)
15.4 Global Cancer Targeted Therapy Consumption Volume Forecast by Application (2023-2028)
15.5 Cancer Targeted Therapy Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
